Lorraine Glover - Avita Medical Insider

Avita Medical Limited -- USA Stock  

USD 1.02  0.05  4.67%

General Manager of Asia Pacific

We currently do not have informatin regarding Lorraine Glover. This executive tanure with Avita Medical Limited is not currenlty determined.
  Executive Since 2008      
44 1763 269770  http://www.avitamedical.com

Management Efficiency

The company has return on total asset (ROA) of (97.34) % which means that it has lost $97.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (192.26) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Found 2 records

EXECUTIVE Since

Joseph LacsonMetro Pacific Investments Corpo
2016
Cristina GilFernandezMetro Pacific Investments Corpo
2013

Entity Summary

Avita Medical Limited, a regenerative medicine company, develops and distributes regenerative solutions for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Avita Medical Limited (AVMXY) is traded on OTC Market in USA. It is located in Royston, SG HB and employs 26 people.

Did you try this?

Run Price Ceiling Movement Now
   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
Hide  View All  Next  Launch Price Ceiling Movement
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Avita Medical Limited to your portfolio

Top Management

Avita Medical Limited Leadership Team
Damien McDonald, Director, MBA
Lou Panaccio, Chairman
Stella Sung, Executive
Jeremy Cook, Director
Ross Saunders, President
Fiona Wood, Director
Louis Drapeau, Director, CPA
Lorraine Glover, Executive
William Marshall, VP
Matt McNamara, Director
Michael Perry, Director, Ph.D
Suzanne Crowe, Director
Gabriel Chiappini, Executive
Andrew Quick, VP
Ian Macpherson, Chairman
Tim Rooney, CEO
Adam Kelliher, CEO
Troy Barring, COO

Stock Performance

Avita Medical Performance Indicators
Return On Equity(192.26) %
Return On Asset(97.34) %
Current Valuation30.68 M
Price to Earning(3.81) times
Price to Book10.66 times
Price to Sales41.57 times
Revenue950.31 K
Gross Profit517.76 K
EBITDA(10.09 M)
Net Income(9.27 M)